Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals Ownership Summary

Acurx Pharmaceuticals is owned by 7.80% institutional investors, 14.80% insiders, and 77.40% retail investors. Vanguard group is the largest institutional shareholder, holding 3.18% of ACXP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.36% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Acurx Pharmaceuticals	7.80%	14.80%	77.40%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	491.69K	3.18%	$1.11M
Prospect financial services	278.10K	1.80%	$625.73K
Geode capital management	130.01K	0.84%	$292.57K
Lpl financial	53.73K	0.35%	$120.90K
Morgan stanley	46.40K	0.30%	$104.40K
State street	43.47K	0.28%	$97.80K
Blackrock	27.50K	0.18%	$61.88K
Northern trust	27.29K	0.18%	$61.39K
Nbc securities	19.00K	0.12%	$42.00K
Td waterhouse canada	18.66K	0.12%	$39.92K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prospect financial services	278.10K	0.48%	$625.73K
Nbc securities	19.00K	0.00%	$42.00K
Patriot financial group insurance agency	10.38K	0.00%	$23.37K
Semmax financial advisors	5.88K	0.00%	$11.17K
Cornerstone planning group	3.34K	0.00%	$6.49K
Td waterhouse canada	18.66K	0.00%	$39.92K
Tocqueville asset management	10.00K	0.00%	$22.50K
Tower research capital llc (trc)	4.14K	0.00%	$9.31K
Gps wealth strategies group	500.00	0.00%	$1.13K
Advisor group	15.21K	0.00%	$34.22K

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	46.40K	-	20.00K
Geode capital management	130.01K	-	13.66K
Lpl financial	53.73K	0.00%	13.50K
Northern trust	27.29K	-	10.13K
Blackrock	27.50K	-	8.81K

Top Sellers

Holder	Shares	% Assets	Change
Advisor group	15.21K	0.00%	-42.04K
Susquehanna group, llp	-	-	-37.44K
Xtx topco	-	-	-13.04K
Two sigma investments, lp	-	-	-12.99K
Cambridge investment research advisors	-	-	-10.00K

New Positions

Holder	Shares	% Assets	Change	Value
Northwestern mutual wealth management	1.64K	-	1.64K	$3.68K
Ubs group	881.00	-	881.00	$1.98K

Sold Out

Holder	Change
Wells fargo & company/mn	-87.00
Cambridge investment research advisors	-10.00K
Two sigma investments, lp	-12.99K
Xtx topco	-13.04K
Susquehanna group, llp	-37.44K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	26	-3.70%	1,206,131	-3.41%	7	8.03%	11	-35.29%	4	33.33%
Mar 31, 2024	27	8.00%	1,248,676	14.30%	9	13.97%	17	-10.53%	3	200.00%
Dec 31, 2023	25	47.06%	1,092,462	24.40%	8	16.18%	19	58.33%	1	-66.67%
Sep 30, 2023	17	41.67%	878,194	-40.86%	7	4.43%	12	50.00%	3	200.00%
Jun 30, 2023	12	-	1,484,920	175.70%	12	59.58%	8	60.00%	1	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	383.81K	2.36%	-
Vanguard Institutional Extnd Mkt Idx Tr	145.54K	0.90%	-
Fidelity Extended Market Index	79.05K	0.49%	8.18K
iShares Micro-Cap ETF	24.88K	0.15%	-
Fidelity Total Market Index	20.10K	0.12%	-
NT Ext Equity Mkt Idx Fd - L	18.93K	0.12%	-
Northern Trust Extended Eq Market Idx	18.93K	0.12%	-
Fidelity Series Total Market Index	18.30K	0.11%	2.94K
Fidelity Nasdaq Composite Index	11.33K	0.07%	-
Spartan Extended Market Index Pool E	10.64K	0.07%	5.36K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 27, 2022	Sailer Carl		Buy	-
Jul 27, 2022	DELUCCIA ROBERT J		Buy	$75.00K
Jul 27, 2022	DELUCCIA ROBERT J		Buy	$70.07K
Jul 27, 2022	DELUCCIA ROBERT J		Buy	-
Jul 27, 2022	LUCI DAVID P	President and CEO	Buy	-

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q2	-	-
2023 Q1	-	-

ACXP Ownership FAQ

Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 7.80%, followed by 14.80% insiders and 77.40% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Vanguard group (491.69K shares, 3.18%), Prospect financial services (278.1K shares, 1.80%), and Geode capital management (130.02K shares, 0.84%). Together, they hold 5.82% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.48% of its assets in 278.1K Acurx Pharmaceuticals shares, valued at 625.72K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Acurx Pharmaceuticals shares, with 2.36% of its total shares outstanding invested in 383.81K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools